TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35760971

Group type: EXPERIMENTAL
Intervention: Extended infusion of piperacillin/tazobactam
Number of subjects: 53

Group type: COMPARATOR
Intervention: Intermittent infusion of piperacillin/tazobactam
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 53
Study: 33320397

Group type: EXPERIMENTAL
Intervention: Cognitive Patient Education combined with active individualized physiotherapy (COPE‐PT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Norwegian Psychomotor Physiotherapy (NPMP)
Number of subjects: 128
Study: 34634975

Group type: EXPERIMENTAL
Intervention: Spanish-speaking patients with low health literacy
Number of subjects: 301

Group type: COMPARATOR
Intervention: English-speaking patients with low health literacy
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Spanish speakers
Number of subjects: 301

Group type: COMPARATOR
Intervention: English speakers
Number of subjects: 301
Study: 34913186

Group type: EXPERIMENTAL
Intervention: Tezepelumab 210 mg every 4 weeks
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Tezepelumab (pooled cohort)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 550
Study: 32664997

Group type: EXPERIMENTAL
Intervention: Visceroceptive interventions focusing on areas pertaining to the gut or heart, running for 8 weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spatial cueing task measuring reaction times to bodily changes relating to lower abdomen or chest focus.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stop/signal task measuring emotional inhibition.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heartbeat estimation task, water load test, and self-report questionnaire to track visceroceptive ability.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 0
Study: 34519614

Group type: EXPERIMENTAL
Intervention: Twitter campaign
Number of subjects: 702

Group type: COMPARATOR
Intervention: Control group (no Twitter campaign)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Prior year's flu shot
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Digital social network structure
Number of subjects: 702
Study: 34398235

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nicotine patches
Number of subjects: 120

Group type: COMPARATOR
Intervention: Varenicline vs Nicotine patches
Number of subjects: 120
Study: 33060783

Group type: EXPERIMENTAL
Intervention: Duodenal acid infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mast cell stabilizer disodiumcromoglycate (DSCG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 0
Study: 35164741

Group type: EXPERIMENTAL
Intervention: Animated picture book group
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 131

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 131
Study: 33997052

Group type: EXPERIMENTAL
Intervention: Diode laser treatment prior to restoration
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nanohybrid composite resin (CR)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Resin‐modified glass ionomer (RMGI)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional glass ionomer (GIC)
Number of subjects: 48
Study: 33372080

Group type: EXPERIMENTAL
Intervention: Open technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Arthroscopic technique
Number of subjects: 100
Study: 34988851

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) prophylaxis
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (no prophylaxis)
Number of subjects: 102
Study: 33044435

Group type: EXPERIMENTAL
Intervention: Low-dose exercise (150 min·wk‐1)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: High-dose exercise (300 min·wk‐1)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control (<75 min·wk‐1)
Number of subjects: 125
Study: 35358372

Group type: EXPERIMENTAL
Intervention: ADRCs
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: ADRCs (dcSSc)
Number of subjects: 88
Study: 32294652

Group type: EXPERIMENTAL
Intervention: Vinpocetine and Dexamethasone (VD group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dexamethasone (D group)
Number of subjects: 60
Study: 32659483

Group type: EXPERIMENTAL
Intervention: Active nVNS (0–30 V, 25 Hz, pulse width = 40 ms)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham stimulation (0–14 V, 0.2 Hz, pulse width = 5s)
Number of subjects: 19
Study: 35299272

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IHM) in centesimal potencies
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 126
Study: 33642331

Group type: EXPERIMENTAL
Intervention: Polyurethane microcuff ETT with pressure volume loop
Number of subjects: 80

Group type: COMPARATOR
Intervention: Polyurethane microcuff ETT with audible leak
Number of subjects: 80

Group type: COMPARATOR
Intervention: PVC ETT with pressure volume loop
Number of subjects: 80

Group type: COMPARATOR
Intervention: PVC ETT with audible leak
Number of subjects: 80
Study: 35916848

Group type: EXPERIMENTAL
Intervention: Graded sensorimotor retraining intervention (RESOLVE)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Sham procedure and attention control
Number of subjects: 276

Group type: COMPARATOR
Intervention: Between-group comparison
Number of subjects: 276
Study: 33576129

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 450
Study: 35379642

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (CDSS) integrated into online laboratory ordering system
Number of subjects: 9683

Group type: COMPARATOR
Intervention: Usual lab ordering system (Control)
Number of subjects: 9683
Study: 34182967

Group type: COMPARATOR
Intervention: Low-level laser therapy (LLLT) with a diode laser (810 nm wavelength, 100 mW power output, 6.29 J/cm2 energy density) applied on days 0, 7, 14, and 21 after loading the canine retraction forces.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 12
Study: 33322157

Group type: EXPERIMENTAL
Intervention: Classroom movement breaks (CMBs) of 15-min with different degrees of difficulty
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: CMBs with optimal cognitive difficulty
Number of subjects: 49
Study: 36160152

Group type: EXPERIMENTAL
Intervention: P2Et
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35633183

Group type: EXPERIMENTAL
Intervention: All-ceramic crowns on zirconia abutments (AC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metal-ceramic crowns on metal abutments (MC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes using OHIP-49 questionnaire
Number of subjects: 30
Study: 33483450

Group type: EXPERIMENTAL
Intervention: Nurse Home Visiting (NHV) program (right@home) with 25 home visits until child age 2 years
Number of subjects: 722

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 722
Study: 33901552

Group type: EXPERIMENTAL
Intervention: Continuous adductor canal block (cACB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous femoral nerve block (cFNB)
Number of subjects: 60
Study: 34033811

Group type: EXPERIMENTAL
Intervention: Prophylactic manual rotation of occiput posterior or occiput transverse position
Number of subjects: 257

Group type: COMPARATOR
Intervention: No trial of prophylactic manual rotation (standard group)
Number of subjects: 257
Study: 33932574

Group type: EXPERIMENTAL
Intervention: PHARM-DC intervention (pharmacist-directed transitional care including medication reconciliation, medication review, increased communication, patient education and counseling)
Number of subjects: 9776

Group type: EXPERIMENTAL
Intervention: PHARM-DC intervention
Number of subjects: 9776
Study: 35843488

Group type: EXPERIMENTAL
Intervention: Strabismus surgery
Number of subjects: 109

Group type: COMPARATOR
Intervention: Contact lens care
Number of subjects: 109

Group type: COMPARATOR
Intervention: Primary intraocular lens implantation
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Visual acuity in study eye
Number of subjects: 109
Study: 34218277

Group type: EXPERIMENTAL
Intervention: Lobectomy
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Particle Beam Therapy (PBT)
Number of subjects: 10000
Study: 35929472

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4401

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 4401
Study: 32372296

Group type: EXPERIMENTAL
Intervention: Mental rotation training (experimental group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 36
Study: 33111932

Group type: EXPERIMENTAL
Intervention: Silicon (Si) at rates of 0, 4.0, 8.0, and 16 g L‐1 under three soil water conditions (50% and 100% of soil water retention capacity and complete submergence in a water blade of 5.0 cm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silicon (Si) at higher rates
Number of subjects: 0
Study: 36035633

Group type: EXPERIMENTAL
Intervention: Iranian regimen including Ficus carica, Vitis vinifera, Safflower, Cicer arietinum, Descurainia sophia seeds, Ziziphus jujuba, chicken soup, barley soup, rose water, saffron, and cinnamon spices
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 32241356

Group type: EXPERIMENTAL
Intervention: Custom cantilever appliance producing 100 g of force for buccal translation
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (no appliance)
Number of subjects: 7
Study: 34224268

Group type: EXPERIMENTAL
Intervention: Colonoscopy and FIT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Colonoscopy alone
Number of subjects: 0
Study: 35475308

Group type: EXPERIMENTAL
Intervention: 75 μg/kg eptacog beta initial dose regimen (IDR)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 225 μg/kg eptacog beta initial dose regimen (IDR)
Number of subjects: 25
Study: 33506907

Group type: EXPERIMENTAL
Intervention: Simulated puncture (research group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no simulated puncture)
Number of subjects: 120
Study: 35684022

Group type: EXPERIMENTAL
Intervention: Conventional Diet
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)-high meal frequency
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)-physical activity
Number of subjects: 155
Study: 33142014

Group type: EXPERIMENTAL
Intervention: Atogepant 170 mg once daily for 28 days
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 36206275

Group type: EXPERIMENTAL
Intervention: Absence of posterior pituitary bright spot (PPBS) in patients with CNS tuberculosis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal MRI brain (control group)
Number of subjects: 100
Study: 34482587

Group type: EXPERIMENTAL
Intervention: PRF group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study: 32151752

Group type: COMPARATOR
Intervention: Brief advice (BA) to exercise alone (minimal treatment control condition)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: BA + supervised and home-based exercise (SHE) + health education (HE)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: BA + SHE + cognitive-behavioral sessions focused on increasing and maintaining exercise (CBEX)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: All interventions (BA, SHE, CBEX)
Number of subjects: 240
Study: 34245094

Group type: EXPERIMENTAL
Intervention: Hospital-supervised exercise
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: Home-supported exercise
Number of subjects: 1146

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 1146
Study: 32147068

Group type: EXPERIMENTAL
Intervention: Aromatherapy with lavender scent (n = 40)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Edible glucose 30% (2 ml, n = 40)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention, n = 40)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 35776030

Group type: EXPERIMENTAL
Intervention: Ketamine-Propofol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ketamine-Midazolam
Number of subjects: 60
Study: 32674651

Group type: EXPERIMENTAL
Intervention: Binaural beat audio created with DMSPS algorithm
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Normal music
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 60
Study: 35197167

Group type: EXPERIMENTAL
Intervention: Active TB diagnosis
Number of subjects: 2160

Group type: EXPERIMENTAL
Intervention: No TB diagnosis
Number of subjects: 2160

Group type: EXPERIMENTAL
Intervention: HIV-positive with active TB
Number of subjects: 2160
Study: 32306485

Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: PE plus sertraline
Number of subjects: 56

Group type: COMPARATOR
Intervention: Combat-exposed controls (CCs)
Number of subjects: 56
Study: 35276995

Group type: EXPERIMENTAL
Intervention: VASpaper
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: VASimages
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: VASno-images
Number of subjects: 17
Study: 33326140

Group type: EXPERIMENTAL
Intervention: Transfusion of erythrocyte concentrates
Number of subjects: 30

Group type: COMPARATOR
Intervention: Athlete Biological Passport
Number of subjects: 30
Study: 33103385

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis ssp. lactis B94 (15 billion)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 34228019

Group type: EXPERIMENTAL
Intervention: Stakeholder Engagement Survey (developed by PCORI)
Number of subjects: 18
Study: 32350172

Group type: EXPERIMENTAL
Intervention: Moderate carbohydrate-restricted diet (targeting 50% of calories) for 6 months
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional calorie-restricted diet using the food exchange table
Number of subjects: 19
Study: 34635569

Group type: EXPERIMENTAL
Intervention: Ivosidenib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ivosidenib (after accounting for crossover)
Number of subjects: 0
Study: 35298833

Group type: EXPERIMENTAL
Intervention: Testosterone gel 2% (5 g/daily) for 24 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 120
Study: 35167505

Group type: EXPERIMENTAL
Intervention: Forearm tourniquet
Number of subjects: 40

Group type: COMPARATOR
Intervention: Upper arm tourniquet
Number of subjects: 40
Study: 34106922

Group type: EXPERIMENTAL
Intervention: Levo-Praziquantel (L-PZQ) ODT 150 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Racemate Praziquantel (Rac-PZQ) ODT 150 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: PZQ 600 mg formulation (PZQ-Cesol) crushed and dispersed in water
Number of subjects: 48
Study: 33309783

Group type: EXPERIMENTAL
Intervention: Multifidus activating exercise
Number of subjects: 241
Study: 34446332

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT), performed once a week for 12 weeks on quadriceps femoris muscles.
Number of subjects: 18
Study: 33731734

Group type: EXPERIMENTAL
Intervention: Manual skills development course (study group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 32318831

Group type: EXPERIMENTAL
Intervention: Scrubbing with an ethanol‐saturated microbrush (MB)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Scrubbing with an ethanol‐saturated microbrush + air polishing (MB + air polishing)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Scrubbing with an ethanol‐saturated cotton pellet (CP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cleaning with a round bur
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Air polishing alone (ProphyFlex, KaVo)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Air/water spray (control group)
Number of subjects: 60
Study: 34229861

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion (1.5 mg.kg-1 bolus over 3 minutes, followed by continuous infusion at 2 mg.kg-1.h-1)
Number of subjects: 85

Group type: COMPARATOR
Intervention: 0.9% normal saline solution (control group)
Number of subjects: 85
Study: 32925634

Group type: EXPERIMENTAL
Intervention: Elective induction of labor
Number of subjects: 4661

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 4661
Study: 33199054

Group type: EXPERIMENTAL
Intervention: Online mental health screening tool
Number of subjects: 126060

Group type: EXPERIMENTAL
Intervention: Online mental health screening tool with in-person care referral
Number of subjects: 126060
Study: 34564685

Group type: EXPERIMENTAL
Intervention: Intra-alveolar administration of dexamethasone 4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral administration of dexamethasone
Number of subjects: 0
Study: 32035662

Group type: EXPERIMENTAL
Intervention: Three-times/week static stretching (2 min of SS thrice per week)
Number of subjects: 24

Group type: COMPARATOR
Intervention: One-time/week static stretching (6 min of SS once per week)
Number of subjects: 24
Study: 35743552

Group type: EXPERIMENTAL
Intervention: ACT‐SS
Number of subjects: 40

Group type: COMPARATOR
Intervention: PCT
Number of subjects: 40
Study: 36227615

Group type: EXPERIMENTAL
Intervention: Capecitabine (1000 mg/m2 twice daily for 14 days every 3 weeks for 8 cycles)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Observation following CCRT (100 mg/m2 cisplatin every 3 weeks for 2 to 3 cycles)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control (Observation)
Number of subjects: 180
Study: 34029648

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA for 20 min)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (2 mA for 20 min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham tDCS (2 mA for 20 min)
Number of subjects: 20
Study: 36103060

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NAC)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: D2-gastrectomy
Number of subjects: 212
Study: 34525837

Group type: EXPERIMENTAL
Intervention: HeartMate 3 left ventricular assist device (HM 3)
Number of subjects: 1015
Study: 33180001

Group type: EXPERIMENTAL
Intervention: spiritually‐integrated cognitive‐behavioral educational group intervention
Number of subjects: 84
Study: 32057811

Group type: EXPERIMENTAL
Intervention: MiFusion TLS2 system (Endotrust, Nettetal Germany)
Number of subjects: 100

Group type: COMPARATOR
Intervention: LigaSure Maryland system (Medtronic, Dublin, Ireland)
Number of subjects: 100
Study: 35366853

Group type: EXPERIMENTAL
Intervention: Beraprost sodium (BPS) 60 μg/day and aspirin 100 mg/day
Number of subjects: 64

Group type: COMPARATOR
Intervention: Aspirin 100 mg/day
Number of subjects: 64
Study: 34453114

Group type: EXPERIMENTAL
Intervention: Personalised behavioural advice facilitated by a trained lay advisor
Number of subjects: 234

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 234
Study: 32128614

Group type: EXPERIMENTAL
Intervention: Intensity-modulated high TENS (IMT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo TENS (PBT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both IMT and PBT
Number of subjects: 20
Study: 36078303

Group type: EXPERIMENTAL
Intervention: Built-shade PRAs
Number of subjects: 1144

Group type: COMPARATOR
Intervention: Control PRAs (unshaded)
Number of subjects: 1144
Study: 34776874

Group type: EXPERIMENTAL
Intervention: Cerebellar intermittent theta-burst stimulation (iTBS)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32
Study: 34533102

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) twice-weekly for 10 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 12
Study: 32988892

Group type: EXPERIMENTAL
Intervention: Minimally access spine surgery (MASS)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Open surgery (OS)
Number of subjects: 49
Study: 34264739

Group type: EXPERIMENTAL
Intervention: Percent of negative urinalysis
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Dichotomous outcome measures
Number of subjects: 441
Study: 35613802

Group type: EXPERIMENTAL
Intervention: JTR-161 (allogeneic human dental pulp stem cells)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 33426790

Group type: EXPERIMENTAL
Intervention: YOTES (Youth Online Training and Employment System) - a moderated, online intervention with vocational, social, and peer motivation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control intervention - headspace Digital Work and Study Service
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: YOTES
Number of subjects: 0
Study: 32963065

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (OACs)
Number of subjects: 0
Study: 35677972

Group type: COMPARATOR
Intervention: Ribavirin aerosol (50 mg/ml, 10 ml total volume)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Ribavirin aerosol (50 mg/ml, 20 ml total volume)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Ribavirin aerosol (100 mg/ml, 10 ml total volume)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Ribavirin aerosol (100 mg/ml, 20 ml total volume)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 34447320

Group type: EXPERIMENTAL
Intervention: VR relaxation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Biofeedback
Number of subjects: 74
Study: 35834302

Group type: EXPERIMENTAL
Intervention: Pharmacist-assisted mHealth (WeChat) intervention based on the Integrated Theory of Health Behavior Change (ITHBC) for TB management
Number of subjects: 114

Group type: COMPARATOR
Intervention: Routine medical and nursing care in the TB clinic (Control group)
Number of subjects: 114